How HIV researchers overcame setbacks and kept a vaccine trial going

Scientists say research into a vaccine for HIV is further along than it’s ever been. But Trump administration cuts to scientific research have set that effort back. Including a promising trial for an HIV vaccine in Africa – which was shut down altogether. NPR’s Ari Daniel has the story of how researchers there refused to give up. Ari’s reporting for this story was supported by a grant from the Pulitzer Center. The Gates Foundation is a financial supporter of NPR. This episode was produced by Mallory Yu and Kira Wakeam. It was edited by Rebecca Davis and Courtney Dorning. Our executive producer is Sami Yenigun.